ReviewBiochemical Society transactions2026
A phase separation hypothesis for the biological function of PrP: the role of multivalent interactions at the plasma membrane.
Review in Biochemical Society transactions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although the prion protein (PrP) is well established as the etiological agent of transmissible spongiform encephalopathies, its biological function remains under debate. Native, cellular PrP (PrPC) is a glycosylphosphatidylinositol-anchored protein that interacts with various proteins and other molecular ligands at the cell surface, triggering diverse cellular responses such as neuritogenesis and neuroprotection. PrPC has been proposed to act as a scaffolding protein, facilitating the assembly of multicomponent complexes at the membrane, with signal transduction occurring through the recruitment of transmembrane proteins. Recent findings demonstrate that PrP undergoes phase separation (PS) in vitro and in cellulo, mostly driven by its multivalency, intrinsically disordered N-terminal domain, and ability to bind polyanions. Considering recent data showing that membrane multicomponent complexes may assemble through PS, we discuss the possible formation of biomolecular condensates containing PrP at the membrane in light of previously described PrP protein ligands. In this mini-review, we examine PrP's interactions with key ligands such as epidermal growth factor receptor, apolipoprotein E, amyloid β oligomers, α-synuclein, N-methyl-D-aspartate receptor, postsynaptic density protein 95, integrin β1, and tau, assessing their relevance in PS-mediated condensate formation. These proteins were selected based on their direct or indirect interaction with PrP, biological effects, presence in a membrane environment, and evidence of participation in biomolecular condensates. Based on current evidence, we propose that PS may be a fundamental mechanism underlying PrP's biological role in the membrane.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.